Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. (EPRXF) Stock Overview
Explore Eupraxia Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
108.3M
P/E Ratio
-2.64
EPS (TTM)
$-1.13
ROE
-4.83%
EPRXF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Eupraxia Pharmaceuticals Inc. (EPRXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $9.41.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.64 and a market capitalization of 108.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.